Who
Nataliya Agafonova
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Longeveron.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Jul 2023
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $7,5452,913 at $2.59 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $16K22,505 at $0.7291 | filing |
| 1 Jul 2026filed 6 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $16K22,505 at $0.73 | filing |
| 1 May 2026filed 5 May 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $15K13,145 at $1.12 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $15K13,145 at $1.12 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $6,07810,250 at $0.593 | filing |
| 2 Jan 2026filed 6 Jan 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $6,04810,250 at $0.59 | filing |
| 1 Oct 2025filed 3 Oct 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $8,79311,883 at $0.74 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —102,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $9,5127,431 at $1.28 | filing |
| 1 Apr 2025filed 3 Apr 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $11K7,566 at $1.50 | filing |
| 2 Jan 2025filed 6 Jan 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $11K6,120 at $1.79 | filing |
| 1 Oct 2024filed 3 Oct 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Code F | $9,9945,316 at $1.88 | filing |
| 15 Aug 2024filed 19 Aug 2024 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,250 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —175,750 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.